The Thailand Board of Investment European office cordially invites medical companies to join the webinar with the BOI headquarters and Food and Drug Administration (FDA) in Bangkok for the latest updates on BOI support measures, laws and regulations on doing business in the Thai medical sector during COVID-19 crisis:

“COVID-19 Opportunities and Investment Support Measures for Medical Industry in Thailand”

Date: 04 June 2020

Time: 11.00-12.00 hrs.

Webinar speakers will share their insights on:
• Current situation, perspectives from the local & international business
communities in Thailand
• Support measures & mitigating measures on COVID-19 outbreak
• Introduction to Thailand Food and Drug Administration
• Basic requirements for health products registrations
• Experience of European companies in doing business in Thailand Speakers will be:

•  Ms. Duangjai ASAWACHINTACHIT, Secretary General,
  Thailand Board of Investment
• Ms. Worasuda YOONGTHONG, Acting Director, Division
  of Innovative Health Products and Services, Thai Food and Drug
  Administration, Ministry of Public Health
• Dr. Armin WIESLER, Head of Animal Health South East
  Asia South Korea, General Manager Thailand, Boehringer Ingelheim
• Mr. Paul SANTING, Director Global Business Development, Steris Ast

The webinar will be held in English.

Participation is complimentary, registration is required: https://register.gotowebinar.com/register/1673293276807382275?source=Germany1